174638-15-4Relevant articles and documents
Use of fosfluridine tidoxil (FT) for the treatment of intraepithelial proliferative diseases
-
Page/Page column 3, (2008/06/13)
The present invention is directed to the systemic administration of Fosfluridine Tidoxil, (5-fluorouridine)-5′-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt thereof, for the treatment of intraepithelial proliferative diseases such as actinic keratosis. The Fosfluridine Tidoxil can be systemically administered alone or in combination with topical treatment agents.